RECENT NEWS
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
What Trump's win means, stronger Ozempic, and cars to avoid: The week's most popular stories
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup